Aandeel JENBURPH6 JENBURKT PHARMACEUTICALS LIMITED
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Jenburkt Pharmaceuticals Limited

Aandelen

JENBURPH6

INE354A01013

Beurs gesloten - Bombay S.E.
Andere beurzen
 12:01:01 05-07-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
877,6 INR -0,10% Intraday-grafiek van Jenburkt Pharmaceuticals Limited +0,59% +29,02%
28/05 Jenburkt Pharmaceuticals Limited kondigt pensionering van bestuursleden aan CI
28/05 Jenburkt Pharmaceuticals Limited kondigt dividend aan CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!
Gratis inschrijven
Jenburkt Pharmaceuticals Limited Announces Board Retirements
Jenburkt Pharmaceuticals Limited Announces Dividend
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Jenburkt Pharmaceuticals Limited Appoints Sumit Ajaybhai Thakkar as A Non-Executive and Independent Director
Jenburkt Pharmaceuticals Limited Appoints Sumit Ajaybhai Thakkar as Non-Executive Independent Director
Jenburkt Pharmaceuticals Limited Approves Dividend for the Financial Year Ended 31 March, 2023
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Jenburkt Pharmaceuticals Limited Approves Dividend
Tranche Update on Jenburkt Pharmaceuticals Limited's Equity Buyback Plan announced on December 1, 2022.
Jenburkt Pharmaceuticals Limited's Equity Buyback announced on December 1, 2022, has closed with repurchase of 176,078 shares, representing 3.84% for INR 114.24 million.
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Jenburkt Pharmaceuticals Limited announces an Equity Buyback for INR 116 million worth of its shares.
Jenburkt Pharmaceuticals Limited authorizes a Buyback Plan.
Jenburkt Pharmaceuticals Board to Consider Share Buyback
Jenburkt Pharmaceuticals Limited's Board intends to launch an Equity Buyback on December 1, 2022.
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers JENBURPH6
  4. Nieuws Jenburkt Pharmaceuticals Limited
  5. Andere talen